ING Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41M Sell
396,489
-77,901
-16% -$6.95M 0.2% 99
2026
Q1
$34.1M Buy
474,390
+87,422
+23% +$6.73M 0.21% 93
2025
Q4
$30.7M Buy
386,968
+243,791
+170% +$19.2M 0.19% 102
2025
Q3
$10.8M Sell
143,177
-24,288
-15% -$1.66M 0.06% 181
2025
Q2
$11.6M Sell
167,465
-44,537
-21% -$2.92M 0.07% 161
2025
Q1
$14.4M Buy
212,002
+63,555
+43% +$3.8M 0.1% 134
2024
Q4
$6.66M Sell
148,447
-20,818
-12% -$1.17M 0.04% 248
2024
Q3
$10.6M Sell
169,265
-127,683
-43% -$7.45M 0.06% 194
2024
Q2
$17.5M Sell
296,948
-153,719
-34% -$9.62M 0.1% 145
2024
Q1
$35.9M Buy
450,667
+123,607
+38% +$9.44M 0.25% 78
2023
Q4
$25.8M Sell
327,060
-256,007
-44% -$18.2M 0.21% 97
2023
Q3
$40.7M Sell
583,067
-385,436
-40% -$27.3M 0.36% 61
2023
Q2
$67M Sell
968,503
-15,906
-2% -$1.13M 0.51% 37
2023
Q1
$73.2M Buy
984,409
+910,673
+1,235% +$76.4M 0.71% 30
2022
Q4
$6.87M Sell
73,736
-133,053
-64% -$12.8M 0.07% 192
2022
Q3
$19.7M Sell
206,789
-41,089
-17% -$4.07M 0.33% 67
2022
Q2
$23M Sell
247,878
-213,560
-46% -$20.8M 0.27% 70
2022
Q1
$46.7M Buy
461,438
+261,246
+130% +$27.4M 0.47% 41
2021
Q4
$20.7M Buy
200,192
+89,058
+80% +$8.23M 0.18% 103
2021
Q3
$9.43M Buy
111,134
+2,235
+2% +$187K 0.12% 125
2021
Q2
$9.09M Buy
108,899
+21,306
+24% +$1.74M 0.14% 105
2021
Q1
$6.59M Buy
87,593
+6
+0% +$437 0.14% 96
2020
Q4
$5.98M Buy
87,587
+55,730
+175% +$3.62M 0.13% 104
2020
Q3
$1.86M Buy
31,857
+17,908
+128% +$1.11M 0.08% 138
2020
Q2
$906K Sell
13,949
-12,746
-48% -$803K 0.04% 133
2020
Q1
$1.58M Sell
26,695
-67,733
-72% -$4.52M 0.07% 151
2019
Q4
$7.01M Buy
94,428
+80,073
+558% +$5.62M 0.21% 84
2019
Q3
$905K Sell
14,355
-72,473
-83% -$4.29M 0.02% 316
2019
Q2
$4.73M Buy
86,828
+35,707
+70% +$1.92M 0.08% 163
2019
Q1
$2.76M Buy
51,121
+8,137
+19% +$502K 0.06% 181
2018
Q4
$2.82M Buy
42,984
+29,922
+229% +$2.23M 0.06% 184
2018
Q3
$1.03M Sell
13,062
-1,890
-13% -$135K 0.02% 358
2018
Q2
$962K Sell
14,952
-3,681
-20% -$243K 0.02% 326
2018
Q1
$1.16M Sell
18,633
-73,391
-80% -$5.27M 0.02% 301
2017
Q4
$6.67M Buy
+92,024
New +$6.69M 0.11% 97
2017
Q2
Sell
-47,824
Closed -$3.75M 846
2017
Q1
$3.75M Sell
47,824
-21,473
-31% -$1.71M 0.07% 174
2016
Q4
$5.47M Buy
69,297
+62,405
+905% +$5.05M 0.1% 131
2016
Q3
$617K Sell
6,892
-18,348
-73% -$1.73M 0.01% 374
2016
Q2
$2.42M Buy
25,240
+4,711
+23% +$470K 0.03% 178
2016
Q1
$2.13M Sell
20,529
-690,490
-97% -$67.1M 0.03% 228
2015
Q4
$69.5M Buy
711,019
+97,236
+16% +$9.52M 0.42% 60
2015
Q3
$59.2M Sell
613,783
-58,086
-9% -$6.11M 0.41% 54
2015
Q2
$70.4M Sell
671,869
-907,169
-57% -$92.7M 0.38% 59
2015
Q1
$163M Sell
1,579,038
-42,269
-3% -$4.28M 0.82% 22
2014
Q4
$156M Buy
1,621,307
+35,955
+2% +$3.17M 0.74% 26
2014
Q3
$126M Sell
1,585,352
-60,699
-4% -$4.78M 0.73% 27
2014
Q2
$124M Buy
1,646,051
+32,314
+2% +$2.44M 0.63% 30
2014
Q1
$121M Sell
1,613,737
-55,905
-3% -$3.95M 0.64% 29
2013
Q4
$119M Buy
1,669,642
+131,562
+9% +$8.45M 0.6% 35
2013
Q3
$87.3M Sell
1,538,080
-268,262
-15% -$16M 0.44% 55
2013
Q2
$103M Buy
+1,806,342
New +$105M 0.55% 48

Other funds holding CVS

ING Group's CVS Position: Q2 2026 in Review

ING Group reduced its CVS Health (CVS) stake by 16% in Q2 2026, selling an estimated $6.95M and leaving 396,489 shares worth $41M. The position accounts for 0.2% of the portfolio, ranked #99.

ING Group first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $163M in Q1 2015. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • ING Group held 396,489 shares of CVS Health worth $41M as of Q2 2026.
  • ING Group sold 77,901 CVS Health shares in Q2 2026, an estimated $6.95M.
  • CVS Health made up 0.2% of ING Group's portfolio in Q2 2026, its #99 holding.
  • ING Group first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • ING Group's CVS Health position peaked at $163M in Q1 2015.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.